Intersectoral cluster of biopharmaceuticals and medical technologies

History

2022: Cluster Begins

In 2022, an intersectoral cluster of biopharmaceuticals and medical technologies was created in Moscow. The main objectives of this project are as follows:

• Consolidation and formation of research and production potential in the field of biomedical technologies and biopharmaceutical products;
• Improvement of R&D infrastructure;
• Industrial implementation of R&D;
• Commercialization of intellectual property objects and access to Russian and foreign markets;
• Elimination of import dependence;
• Improving the quality and safety of biopharmaceutical products

As the head of the Department of Investment and Industrial Policy of Moscow Vladislav Ovchinsky said in January 2023, the cluster of pharmaceuticals created in the special economic zone of the capital included 9 enterprises that develop and produce innovative medicines. It is planned that in the coming years several more companies will join the association, and by January 11, 2023 they will complete the construction of drug production in the SEZ "Technopolice Moscow," he said.

Deputy Mayor of Moscow for Economic Policy and Property and Land Relations Vladimir Efimov noted that in total in 2022 three clusters were created in the capital, about 100 organizations joined them.

In addition, Sechenov University created an intersectoral cluster of biopharmaceuticals and medical technologies. Its goal is to consolidate and form research and production potential in the field of biomedical technologies and biopharmaceutical products, improve research and development infrastructure, commercialize intellectual property objects and enter Russian and foreign markets, as well as improve the quality and safety of biopharmaceutical products. In 2022, the intersectoral cluster included 62 participants.^[1]

Notes